Cargando…
Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV−ve Oropharynx cancer? A population-based study
BACKGROUND: In the absence of clear evidence on the efficacy of concurrent chemoradiotherapy (CRT) over conventional radiotherapy (RT) for HPV+ve and for HPV−ve oropharyngeal cancer (OPC), this study compares the treatments and outcomes from pre-CRT years to post-CRT years. METHODS: A population-bas...
Autores principales: | Hall, Stephen F, Liu, Fei-Fei, O'Sullivan, Brian, Shi, Willa, Rohland, Susan, Griffiths, Rebecca, Groome, Patti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674099/ https://www.ncbi.nlm.nih.gov/pubmed/28829763 http://dx.doi.org/10.1038/bjc.2017.275 |
Ejemplares similares
-
Differential Inhibitory Effects of Curcumin Between HPV+ve and HPV–ve Oral Cancer Stem Cells
por: Bano, Nasreen, et al.
Publicado: (2018) -
The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low‐risk HPV‐related oropharyngeal cancer in a real‐world setting
por: Hall, Stephen F., et al.
Publicado: (2019) -
HPV(+ve/−ve) oral-tongue cancer stem cells: A potential target for relapse-free therapy
por: Gupta, Shilpi, et al.
Publicado: (2020) -
They've said it, they've done it
por: Association
Publicado: (2007) -
Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer
por: Bahig, Houda, et al.
Publicado: (2020)